Novel Approaches to Phenotyping Drug Abuse

The summary for the Novel Approaches to Phenotyping Drug Abuse grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Novel Approaches to Phenotyping Drug Abuse: The National Institute on Drug Abuse (NIDA) requests applications that propose and evaluate novel approaches to understanding the drug abuse phenotype(s). Specifically, the purpose of this initiative is to support innovative studies that better describe, discriminate, and predict the complex nature and course of drug abuse so as to offer more precise phenotypic indicators for testing the hypothesized underlying genetic and environmental risks for drug abuse. The term "drug abuse" as used in this RFA refers broadly to several different but related concepts including drug abuse and drug dependence as defined by diagnostic criteria, as well as drug involvement, hazardous drug use, drug seeking behavior, and the like. While it is recognized that these concepts may not be interchangeable, the term drug abuse is used for the purposes of fluency. The term "drug" refers primarily to cannabis, cocaine, opiates, nicotine, but also includes the entire range of substances of abuse. Like other common human diseases, drug abuse is considered a "complex" disorder that reflects the interplay between underlying genetic susceptibility and environmental risk. Despite the real promise of molecular genetics, there has been limited success in reliably identifying specific susceptibility genes for drug abuse. Although this difficulty is often attributed to genetic heterogeneity, attaining greater clarity of the phenotypic heterogeneity of drug abuse looms large as a major challenge for the field. Ultimately, the successful identification of specific genes and related mechanisms, underlying physiologic systems, and other etiological processes hinges on precise and specific phenotypic definitions and greater understanding of how such phenotypes influence and are shaped by environmental factors, developmental course, and individual characteristics. Although researchers and treatment providers acknowledge that drug abuse is diverse, complex, and dynamic, such knowledge has not been well integrated into research, treatment, and prevention strategies. For example, while extant research conceptualizes drug abuse as a heterogeneous and dynamic construct, most analytic approaches operationalize drug abuse as a dichotomous and static outcome, and consider as covariates (or even statistical error) factors that may represent critical clues about drug abuse etiology, treatment, prevention and, ultimately, genomic search strategies.
Federal Grant Title: Novel Approaches to Phenotyping Drug Abuse
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-04-005
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Jan 22, 2004
Posted Date: Sep 23, 2003
Creation Date: Feb 21, 2004
Archive Date: Feb 21, 2004
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, An...
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
Research Networks for the Study of Recovery Support Services for Persons Treated with Medi...
The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowe...
The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020